# Efficacy of Gralise® for Chronic Pelvic Pain

> **NCT01678911** · PHASE4 · TERMINATED · sponsor: **Shirley Ryan AbilityLab** · enrollment: 11 (actual)

## Conditions studied

- Irritable Bowel Syndrome
- Ulcerative Colitis
- Interstitial Cystitis
- Prostatitis
- Pelvic Pain

## Interventions

- **DRUG:** Gralise

## Key facts

- **NCT ID:** NCT01678911
- **Lead sponsor:** Shirley Ryan AbilityLab
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Study ended due to difficulties in recruitment and low enrollment.
- **Last updated:** 2015-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01678911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01678911, "Efficacy of Gralise® for Chronic Pelvic Pain". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01678911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*